In the present investigation, we performed a stringentimmunohistochemicalanalysis to study the protein expression of ACE2 both in the normalhuman brain and in clinical samples from COVID-19 patients with variousdegrees of neurological symptoms. The gene discussed is ACE2; the disease is COVID-19.